Clinical trial
A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin…
NCT00447421 · Eli Lilly and Company, Industry · Terminated
Key facts
| NCT number | NCT00447421 |
|---|---|
| Title | A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy |
| Official title | Phase I/II Study of Concurrent Cisplatin, Pemetrexed, and Radiotherapy for Limited Stage Small Cell Lung Cancer |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Small Cell Lung Cancer, Carcinoma, Small Cell, SCLC |
| Intervention type | Drug, Radiation |
| Interventions | pemetrexed, cisplatin, radiation |
| Enrollment | 9 |
| Start date | Feb 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 14, 2007 |
| Last update posted | Oct 28, 2009 |
| Countries | Belgium, Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: